🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
1.810
-0.050 (-2.69%)
At close: Nov 20, 2026, 4:00 PM EST
1.840
+0.030 (1.66%)
After-hours: Nov 20, 2026, 5:33 PM EST

BBOT Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Cash & Equivalents
76.48373.6930.850.25
Short-Term Investments
117.3951.77124.78-
Cash & Short-Term Investments
193.87425.46155.630.25
Cash Growth
-58.60%173.38%62152.40%-
Other Receivables
0.160.390.081.72
Receivables
0.160.390.081.72
Prepaid Expenses
14.36.552.981.96
Total Current Assets
208.33432.4158.693.94
Property, Plant & Equipment
2.83.290.490.6
Other Long-Term Assets
13.6312.75.121.41
Total Assets
346.22448.38164.35.94

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Accounts Payable
10.261.373.070.58
Accrued Expenses
39.9632.6112.923.54
Current Portion of Leases
0.570.52--
Other Current Liabilities
0.230.533.5912.66
Total Current Liabilities
51.0335.0419.5816.78
Long-Term Leases
1.812.24--
Total Liabilities
52.8437.2919.5816.78

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Common Stock
0.010.01--
Additional Paid-In Capital
784.38767.6443.5432.61
Retained Earnings
-489.3-356.57-222.52-148.25
Comprehensive Income & Other
-1.70.020.35-
Total Common Equity
293.39411.1-178.64-115.64
Shareholders' Equity
293.39411.1144.72-10.83
Total Liabilities & Equity
346.22448.38164.35.94

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Total Debt
2.382.77--
Net Cash (Debt)
312.95422.69155.630.25
Net Cash Growth
-32.76%171.60%62152.40%-
Net Cash Per Share
3.9013.5712061.612.00
Filing Date Shares Outstanding
80.2580.030.320.12
Total Common Shares Outstanding
80.2379.990.320.12
Working Capital
157.3397.36139.11-12.84
Book Value Per Share
3.665.14-558.92-927.16
Tangible Book Value
293.39411.1-178.64-115.64
Tangible Book Value Per Share
3.665.14-558.92-927.16